Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-004267-30Phase 3Completed
Phase 3 trial of dexibuprofen and ibuprofen in tonsillopharyngitis (2 arms), sponsored by Gebro Pharma. Primary endpoints: SPID0-4 and TOTPAR0-4. Started Jun 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-004267-30.